Skip to main content

Table 1 Cuban patients studied (n = 104), according to their genotype for the TaqI polymorphism of the VDR gene and the possibility of a clinical form -whether non symptomatic or symptomatic- compared to the risk of presenting another clinical forms

From: TaqI polymorphism of the VDR gene: aspects related to the clinical behavior of COVID-19 in Cuban patients

Clinical forms Genotypes for the TaqI polymorphism
tt Tt TT
No OR (IC = 95%) No OR (IC = 95%) No OR (IC = 95%)
Symptomatic (n = 81) 7 2.081
[0.243–17.842]
34 0.465
[0.180–1.198]
40 1.829
[0.699–4.788]
Non symptomatic (n = 23) 1 0.481
[0.056–4.120]
14 2.150
[0.835–5.541]
8 0.547
[0.209–1.431]
  1. OR: odds ratio
  2. CI: confidence interval